Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001571049-16-013302
Filing Date
2016-03-23
Accepted
2016-03-23 17:15:09
Documents
1
Group Members
JACK C. BENDHEIM

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 5 TO SCHEDULE 13D t1600806_sc13da.htm SC 13D/A 42874
  Complete submission text file 0001571049-16-013302.txt   44572
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Subject) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13D/A | Act: 34 | File No.: 005-88114 | Film No.: 161524628
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 FRANK W. BURR BLVD., STE 21 TEANECK NJ 07666
Business Address 300 FRANK W. BURR BLVD., STE 21 TEANECK NJ 07666 2013297300
BFI Co., LLC (Filed by) CIK: 0001601607 (see all company filings)

EIN.: 262105186 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A